Menu
Recruiting NCT06589505

Software as a Medical Device for the Treatment of Patients With PTSD

Phase II / Phase III Interventional Post-Traumatic Stress Disorder, PTSD

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Software as a Medical Device.
Who it may be relevant to
Registry conditions: Post-Traumatic Stress Disorder, PTSD. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Japan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Multicenter, Randomized, Double-blind, Parallel-group Comparative Study to Assess Efficacy and Safety of Software as a Medical Device in Patients With Post-Traumatic Stress Disorder (PTSD)

Overview

To evaluate the efficacy and safety of Software as a Medical Device in patients with Post-Traumatic Stress Disorder (PTSD)

Interventions

  • Device Software as a Medical Device
    The subject will undergo treatment using the Software as a Medical Device

Primary outcome measures

  • Clinician-Administered PTSD Scale for DSM-5 [Time frame: baseline and after intervention (up to 21 weeks)]

Eligibility criteria

Inclusion criteria

  • Diagnosis of PTSD according to the DSM-5
  • Subjects who are within 1 to 20 years since index trauma

Exclusion criteria

  • Subjects diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, bipolar I disorder, autism spectrum disorder, or intellectual disability based on DSM-5.
  • Subjects diagnosed with any mood disorder and anxiety disorder according to DSM-5 that is the primary focus of treatment in the last 6 months prior to screening, as per the clinical judgement of the investigator
  • Subjects who have completed two or more full courses of trauma-focused therapy in the past

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Treatment

Study locations

Japan · 35 centers
  • Yamanashi Prefectural Kita Hospital — Yamanashi
  • Heart Care Clinic Omachi — Akita
  • Aburayama Hospital — Fukuoka
  • Ai Sakura Clinic — Fukuoka
  • Hatakeyama Clinic — Fukuoka
  • Hiro Mental Clinic — Fukuoka
  • Hirota Clinic — Fukuoka
  • Kurume University Hospital — Fukuoka
  • … and 27 more centers

Identifiers

NCT: NCT06589505 · 380-102-0001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗